These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27894333)

  • 1. Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
    Jorge-Nebert LF; Zhang G; Wilson KM; Jiang Z; Butler R; Gluckman JL; Pinney SM; Nebert DW
    Hum Genomics; 2016 Nov; 10(1):39. PubMed ID: 27894333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
    Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
    Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption.
    Josse AR; Da Costa LA; Campos H; El-Sohemy A
    Am J Clin Nutr; 2012 Sep; 96(3):665-71. PubMed ID: 22854411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cytochrome P450 1B1 haplotypes with head and neck cancer risk.
    Katiyar T; Maurya SS; Hasan F; Singh AP; Khan AJ; Hadi R; Singh S; Bhatt MLB; Parmar D
    Environ Mol Mutagen; 2017 Jul; 58(6):443-450. PubMed ID: 28556360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
    Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
    Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
    Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil.
    Abnet CC; Fagundes RB; Strickland PT; Kamangar F; Roth MJ; Taylor PR; Dawsey SM
    Carcinogenesis; 2007 Jan; 28(1):112-7. PubMed ID: 16864595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.
    Söderberg MM; Haslemo T; Molden E; Dahl ML
    Pharmacogenet Genomics; 2013 May; 23(5):279-85. PubMed ID: 23492908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of interaction between maternal polycyclic aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart diseases.
    Li N; Mu Y; Liu Z; Deng Y; Guo Y; Zhang X; Li X; Yu P; Wang Y; Zhu J
    Sci Rep; 2018 Feb; 8(1):3075. PubMed ID: 29449662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
    Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
    Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
    Matheus LHG; Dalmazzo SV; Brito RBO; Pereira LA; de Almeida RJ; Camacho CP; Dellê H
    BMC Cancer; 2020 Sep; 20(1):869. PubMed ID: 32907554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with β-naphthoflavone.
    Brauze D; Fijalkiewicz K; Szaumkessel M; Kiwerska K; Bednarek K; Rydzanicz M; Richter J; Grenman R; Jarmuz-Szymczak M
    Toxicol Lett; 2014 Nov; 231(1):99-107. PubMed ID: 25218365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CYP1A1 and CYP1B1 polymorphisms with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Chávez B; Vilchis F; Rojano-Mejía D; Coral Vázquez RM; Aguirre-García MDC; Canto P
    Gynecol Endocrinol; 2017 Aug; 33(8):607-610. PubMed ID: 28300467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
    Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
    Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
    Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
    Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.
    Chang TK; Chen J; Pillay V; Ho JY; Bandiera SM
    Toxicol Sci; 2003 Jan; 71(1):11-9. PubMed ID: 12520071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk.
    Shen M; Hu YY; Hu YK; Xie LC; Xu XM; Wu MY; Niu YM
    Tumour Biol; 2014 Apr; 35(4):3891-7. PubMed ID: 24343338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer.
    Spink BC; Bloom MS; Wu S; Sell S; Schneider E; Ding X; Spink DC
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):30-41. PubMed ID: 25447411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.